APA (7th ed.) Citation

Weide, B. M., Hassel, J. C., & Gebhardt, C. (2016). Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab. Clinical cancer research, 22(22), . https://doi.org/10.1158/1078-0432.CCR-16-0127

Chicago Style (17th ed.) Citation

Weide, Benjamin Matthias, Jessica C. Hassel, and Christoffer Gebhardt. "Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab." Clinical Cancer Research 22, no. 22 (2016). https://doi.org/10.1158/1078-0432.CCR-16-0127.

MLA (9th ed.) Citation

Weide, Benjamin Matthias, et al. "Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab." Clinical Cancer Research, vol. 22, no. 22, 2016, https://doi.org/10.1158/1078-0432.CCR-16-0127.